Nageswararao Pulakundam

Nageswararao Pulakundam

Auto-generated profile, based on publicly available information

Nageswararao Pulakundam

Drug Metabolism Pharmacokinetics and Bioanalysis, Eurofins Advinus Biopharma Services India Pvt Ltd., 21 and 22, Phase II, Peenya Industrial Area, Bengaluru-560058, India. Department of Chemistry, PAHER University, Udaipur, Rajasthan, India

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 September 2026 in International Journal of Applied Pharmaceutics
Verified
Journal Article
Open access
PDF file
NPNageswararao Pulakundam
Nageswararao Pulakundam
BPBhavesh D. Patel
Bhavesh D. Patel
NPNaresh P.
Naresh P.
MJMonika Jangid
Monika Jangid
PTParas Tak
Paras Tak
Objective: This study aimed to develop and validate a sensitive LC–MS/MS method for quantifying a novel Secretory phospholipase A₂ (sPLA₂) inhibitor, compound-7(L), in mouse plasma and to evaluate its application in pharmacokinetic studies. Methods: A bioanalytical LC–MS/MS method was developed and validated according to ICH M10 guidelines. Compound-7(L) was extracted from mouse plasma using protein precipitation. Pharmacokinetic studies were conducted in male C57BL/6 mice following intravenous administration at a dose of 1 mg/kg. Results: The method was linear over the range of 0.100–100 ng/ml with regression coefficient>0.99. Intra-and Inter-run accuracy ranged from 89.67% to 105.00% and 90.00 % to100%, respectively. The intra-and inter-day precision values were1.88% to 9.52% and 0.30 % to 4.00%, respectively. All stability assessments were within acceptance criteria of ±15%. Conclusion: The method exhibits excellent specificity and selectivity, with well-fitted linearity over the validated concentration range. The established method, validated in line with ICH M10 guidelines, was shown to be accurate, precise, rugged, and stable in mouse plasma, meeting all specified acceptance criteria. Overall, the validated method, owing to its simplicity, sensitivity, and cost‑effectiveness, is suitable for mouse plasma analysis and supports its application in pharmacokinetic study.